DHR Insider Trading

Insider Ownership Percentage: 11.10%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $31,481,128.21

Danaher Insider Trading History Chart

This chart shows the insider buying and selling history at Danaher by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$20M$0$20MTotal Insider BuyingTotal Insider Selling

Danaher Share Price & Price History

Current Price: $196.01
Price Change: Price Decrease of -1.13 (-0.57%)
As of 04/28/2025 04:59 PM ET

This chart shows the closing price history over time for DHR up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
JunJulAugSepOctNovDecJanFebMarApr$196.01Closing price on 04/28/25:

SEC Filings (Institutional Ownership Changes) for Danaher (NYSE:DHR)

79.05% of Danaher stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at DHR by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$694Mbought$250MsoldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$200B-$100B$0$100B$200BTotal InflowsTotal Outflows
Danaher logo
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; microscopes; protein consumables; industrial filtration products; and genomic medicines, such as custom nucleic acid products, plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX and SCIEX brands. The Diagnostics segment offers chemistry, immunoassay, microbiology, and automation systems; and molecular, acute care, and pathology diagnostics products. This segment also provides clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is based in Washington, the District of Columbia.
Read More on Danaher

Today's Range

Now: $196.01
Low: $194.29
High: $199.44

50 Day Range

MA: $200.69
Low: $173.85
High: $214.76

52 Week Range

Now: $196.01
Low: $171.00
High: $281.70

Volume

2,715,127 shs

Average Volume

3,339,063 shs

Market Capitalization

$140.28 billion

P/E Ratio

37.12

Dividend Yield

0.65%

Beta

0.86

Who are the company insiders with the largest holdings of Danaher?

Danaher's top insider shareholders include:
  1. Alan G Spoon (Director)
  2. Rainer Blair (CEO)
  3. Joakim Weidemanis (EVP)
  4. Linda Filler (Director)
  5. Daniel Raskas (SVP)
  6. Brian W Ellis (SVP)
  7. Matthew Mcgrew (CFO)
  8. Teri List (Director)
  9. Walter G Lohr (Director)
  10. Jose-Carlos Gutierrez-Ramos (SVP)
  11. Georgeann Couchara (SVP)
Learn More about top insider investors at Danaher.

Who are the major institutional investors of Danaher?

Danaher's top institutional shareholders include:
  1. Principal Financial Group Inc. — 0.42%
  2. Bessemer Group Inc. — 0.36%
  3. Sumitomo Mitsui Trust Group Inc. — 0.28%
  4. GAMMA Investing LLC — 0.26%
  5. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA — 0.23%
  6. Rhumbline Advisers — 0.15%
Learn More about top institutional investors of Danaher stock.

Which major investors are selling Danaher stock?

During the last quarter, DHR stock was sold by these institutional investors:
  1. Allspring Global Investments Holdings LLC
  2. Rhumbline Advisers
  3. Franklin Street Advisors Inc. NC
  4. Stock Yards Bank & Trust Co.
  5. Handelsbanken Fonder AB
  6. Greystone Financial Group LLC
  7. Border to Coast Pensions Partnership Ltd
  8. New York State Teachers Retirement System
In the last year, company insiders that have sold Danaher company stock include:
  1. Alan G Spoon (Director)
  2. Rainer Blair (CEO)
  3. Joakim Weidemanis (EVP)
  4. Linda Filler (Director)
  5. Daniel Raskas (SVP)
  6. Brian W Ellis (SVP)
Learn More investors selling Danaher stock.

Which major investors are buying Danaher stock?

Within the last quarter, DHR stock was acquired by institutional investors including:
  1. GAMMA Investing LLC
  2. Manning & Napier Advisors LLC
  3. SG Americas Securities LLC
  4. Bessemer Group Inc.
  5. DAVENPORT & Co LLC
  6. Sumitomo Mitsui Trust Group Inc.
  7. Artemis Investment Management LLP
  8. Johnson Investment Counsel Inc.